Found: 27
Select item for more details and to access through your institution.
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML‐001.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 877, doi. 10.1111/bjh.19202
- By:
- Publication type:
- Article
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1685, doi. 10.1002/ajh.27046
- By:
- Publication type:
- Article
Multistep pathogenesis of chronic myelomonocytic leukemia in patients.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 1, p. 50, doi. 10.1111/ejh.13768
- By:
- Publication type:
- Article
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents—A Prospective Cohort Study of the AGMT Study-Group.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2459, doi. 10.3390/cancers14102459
- By:
- Publication type:
- Article
Is Myelodysplasia a Consequence of Normal Aging?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01136-5
- By:
- Publication type:
- Article
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 2, p. 265, doi. 10.1111/ejh.13647
- By:
- Publication type:
- Article
CPX‐351 (Vyxeos<sup>®</sup>) can cause severe rash in acute myeloid leukemia—A case report.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 4, p. 1933, doi. 10.1002/ccr3.3909
- By:
- Publication type:
- Article
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6057, doi. 10.3390/ijms21176057
- By:
- Publication type:
- Article
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study.
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00174-2
- By:
- Publication type:
- Article
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1891, doi. 10.3390/cancers12071891
- By:
- Publication type:
- Article
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML): A representative and useful real-life data source for further biomedical research.
- Published in:
- Wiener Klinische Wochenschrift, 2019, v. 131, n. 17/18, p. 410, doi. 10.1007/s00508-019-1526-1
- By:
- Publication type:
- Article
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 789, doi. 10.3390/ijms20030789
- By:
- Publication type:
- Article
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 11, p. 547, doi. 10.1002/gcc.22667
- By:
- Publication type:
- Article
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 17/18, p. 517, doi. 10.1007/s00508-018-1355-7
- By:
- Publication type:
- Article
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 3/4, p. 115, doi. 10.1007/s00508-018-1315-2
- By:
- Publication type:
- Article
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 415, doi. 10.3390/ijms18020415
- By:
- Publication type:
- Article
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French- American-British and World Health Organization classifications.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0263-4
- By:
- Publication type:
- Article
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 809, doi. 10.1002/gcc.22292
- By:
- Publication type:
- Article
10th anniversary of the Austrian MDS Platform: aims and ongoing projects.
- Published in:
- Wiener Klinische Wochenschrift, 2015, v. 127, n. 1/2, p. 12, doi. 10.1007/s00508-014-0627-0
- By:
- Publication type:
- Article
Proposed score for survival of patients with myelodysplastic syndromes.
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 11, p. 1120, doi. 10.1111/eci.12149
- By:
- Publication type:
- Article
Tumor-Stammzellforschung – Basis und Herausforderung für Diagnostik und Therapie.
- Published in:
- Wiener Klinische Wochenschrift, 2010, v. 122, n. 13/14, p. 423, doi. 10.1007/s00508-010-1408-z
- By:
- Publication type:
- Article
Meeting report: Vienna 2008 Workshop of the German–Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 7, p. 607, doi. 10.1007/s00277-008-0673-7
- By:
- Publication type:
- Article
Die individualisierte Riskoeinschätzung und Therapieplanung bei myelodysplastischen Syndromen.
- Published in:
- Wiener Klinische Wochenschrift, 2008, v. 120, n. 17/18, p. 523, doi. 10.1007/s00508-008-1058-6
- By:
- Publication type:
- Article
Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?
- Published in:
- Annals of Hematology, 2006, v. 85, n. 6, p. 386, doi. 10.1007/s00277-005-0074-0
- By:
- Publication type:
- Article
Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes.
- Published in:
- Journal of Molecular Medicine, 2003, v. 81, n. 7, p. 435, doi. 10.1007/s00109-003-0447-6
- By:
- Publication type:
- Article
Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Gα16 and 5′-lipoxygenase.
- Published in:
- Annals of Hematology, 2002, v. 81, n. 11, p. 632, doi. 10.1007/s00277-002-0536-6
- By:
- Publication type:
- Article
Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.
- Published in:
- British Journal of Haematology, 1999, v. 106, n. 2, p. 455, doi. 10.1046/j.1365-2141.1999.01559.x
- By:
- Publication type:
- Article